Search

everythinglearnresearchcommunity

for

Search:↓

Various substances, quitting smoking, and certain topical applications can enhance the survival of skin flaps used in surgery. Oxygen-free radicals play a role in tissue injury, but certain treatments can have beneficial effects.

Some people experienced hair loss after mesotherapy treatments for hair loss.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

FGF-2&D/P nanoparticles can help treat hair loss.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

Some blood thinners can cause hair loss, but switching medications can stop it.

Psychotropic drugs can cause hair loss or excessive hair growth.

Most patients experience temporary hair loss after ECMO, but it usually grows back within 6 months without treatment.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

The document says that there are treatments for hair and nail diseases.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Mesotherapy and platelet-rich plasma treatments may help with hair loss, but their safety and effectiveness are still uncertain.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.